Satoshi Sakaguchi

640 total citations
25 papers, 300 citations indexed

About

Satoshi Sakaguchi is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Physiology. According to data from OpenAlex, Satoshi Sakaguchi has authored 25 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 6 papers in Physiology. Recurrent topics in Satoshi Sakaguchi's work include Lung Cancer Treatments and Mutations (6 papers), Biomedical Ethics and Regulation (4 papers) and Ethics in Clinical Research (4 papers). Satoshi Sakaguchi is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Biomedical Ethics and Regulation (4 papers) and Ethics in Clinical Research (4 papers). Satoshi Sakaguchi collaborates with scholars based in Japan. Satoshi Sakaguchi's co-authors include Yasutaka Ishii, Yasushi Obora, Hisatsugu Goto, Yasuhiko Nishioka, Soji Kakiuchi, Masaki Hanibuchi, Yuko Toyoda, Atsuro Saijo, Kenji Otsuka and Hiroshi Kawano and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Organic Chemistry and Journal of Medical Internet Research.

In The Last Decade

Satoshi Sakaguchi

23 papers receiving 295 citations

Peers

Countries citing papers authored by Satoshi Sakaguchi

Since Specialization

Citations

This map shows the geographic impact of Satoshi Sakaguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoshi Sakaguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoshi Sakaguchi more than expected).

Fields of papers citing papers by Satoshi Sakaguchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoshi Sakaguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoshi Sakaguchi. The network helps show where Satoshi Sakaguchi may publish in the future.

Co-authorship network of co-authors of Satoshi Sakaguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Satoshi Sakaguchi. A scholar is included among the top collaborators of Satoshi Sakaguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoshi Sakaguchi. Satoshi Sakaguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Asciminib, a novel allosteric inhibitor of BCR‐ABL1, shows synergistic effects when used in combination with imatinib with or without drug resistance 2024 ·Pharmacology Research & Perspectives ·Naoki Okamoto, Kenta Yagi, (unknown), (unknown), Fuka Aizawa, Takahiro Niimura, Mitsuhiro Goda, Kôji Miyata, Kei Kawada, Yuki Izawa‐Ishizawa, Satoshi Sakaguchi, Keisuke Ishizawa	8
2	Effects of vonoprazan and proton pump inhibitors on the efficacy of bevacizumab: a multicentre retrospective study 2023 ·Clinical and Experimental Medicine ·Kenta Yagi, (unknown), (unknown), Fuka Aizawa, Soichiro Ushio, Satoshi Sakaguchi, (unknown), Takahiro Niimura, Mitsuhiro Goda, Hirofumi Hamano, Yuki Izawa‐Ishizawa, Yoshito Zamami, Keisuke Ishizawa	4
3	Differential effects of proton pump inhibitors and vonoprazan on vascular endothelial growth factor expression in cancer cells 2022 ·Drug Development Research ·(unknown), Kenta Yagi, (unknown), (unknown), (unknown), Ryusuke Sawada, (unknown), Kôji Miyata, Fuka Aizawa, Hirofumi Hamano, Takahiro Niimura, Yuki Izawa‐Ishizawa, Mitsuhiro Goda, Satoshi Sakaguchi, Yoshito Zamami, Yoshihiro Yamanishi, Keisuke Ishizawa	3
4	Research Ethics Consultation in Nursing Studies 2021 ·Journal of Empirical Research on Human Research Ethics ·(unknown), Satoshi Sakaguchi, Masayuki Chuma, Kenta Yagi, Kenshi Takechi, (unknown), (unknown), Hiroaki Yanagawa	2
5	Academic investigators’ interest in promoting specified clinical trials : Questionnaire survey before and after implementation of the Clinical Trial Act 2021 ·The Journal of Medical Investigation ·Masayuki Chuma, Kenshi Takechi, Kenta Yagi, Satoshi Sakaguchi, Hiroshi Nokihara, (unknown), Yasutaka Sato, Takahiro Niimura, Mitsuhiro Goda, Yoshito Zamami, Keisuke Ishizawa, Hiroaki Yanagawa	1
6	Radiation-associated Angiosarcoma Presenting as Massive Pleural Effusion 2021 ·Internal Medicine ·Hirokazu Ogino, (unknown), (unknown), Hiroshi Kawano, Satoshi Sakaguchi, Atsuro Saijo, Daisuke Matsumoto, Hiromitsu Takizawa, (unknown), Yoshimi Bando, Hisatsugu Goto, Hiroshi Nokihara, Yasuhiko Nishioka	3
7	Introduction of Clinical Trial Document Support System for Document Management of Registration Trials: Outcome Evaluation in a Japanese University Hospital 2020 ·Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics ·Kazuki Maeda, Kenshi Takechi, Masayuki Chuma, (unknown), Satoshi Sakaguchi, Hiroaki Yanagawa	0
8	Status of Institutional Review Board Meetings Conducted Through Web Conference Systems in Japanese National University Hospitals During the COVID-19 Pandemic: Questionnaire Study 2020 ·Journal of Medical Internet Research ·Kenta Yagi, Kazuki Maeda, Satoshi Sakaguchi, Masayuki Chuma, Yasutaka Sato, (unknown), (unknown), Keisuke Ishizawa, Hiroaki Yanagawa	1
9	An educational workshop designed for research ethics consultants to educate investigators on ethical considerations 2020 ·Hiroaki Yanagawa, Masayuki Chuma, Kenshi Takechi, Kenta Yagi, Yasutaka Sato, (unknown), Satoshi Sakaguchi, (unknown), Yusuke Inoue, Kenji Matsui	1
10	The clinical features of older patients with lung cancer in comparison with their younger counterparts 2018 ·Respiratory Investigation ·Hirokazu Ogino, Masaki Hanibuchi, Satoshi Sakaguchi, Yuko Toyoda, (unknown), Hiroshi Kawano, Soji Kakiuchi, Kenji Otsuka, Atsuro Saijo, Masahiko Azuma, Hiroshi Nokihara, Hisatsugu Goto, Yasuhiko Nishioka	4
11	A multicenter, open-label, phase II trial of S-1 plus carboplatin in advanced non-small cell lung cancer patients with interstitial lung disease 2018 ·Lung Cancer ·Masaki Hanibuchi, Soji Kakiuchi, Shinji Atagi, Fumitaka Ogushi, Eiji Shimizu, Takashi Haku, Yuko Toyoda, Masahiko Azuma, (unknown), Hiroshi Kawano, Kenji Otsuka, Satoshi Sakaguchi, Hiroshi Nokihara, Hisatsugu Goto, Yasuhiko Nishioka	20
12	A case of pulmonary pleomorphic carcinoma with malignant phenotypes induced by ZEB1-associated epithelial-mesenchymal transition 2018 ·Respiratory Medicine Case Reports ·(unknown), Hirokazu Ogino, Hirohisa Ogawa, (unknown), Yuko Toyoda, Satoshi Sakaguchi, (unknown), Yoshimi Bando, Hisatsugu Goto, Koichi Tsuneyama, Yasuhiko Nishioka	5
13	Analysis of acute exacerbation of interstitial lung disease associated with chemotherapy in patients with lung cancer: A feasibility of S-1 2016 ·Respiratory Investigation ·Soji Kakiuchi, Masaki Hanibuchi, (unknown), Atsuro Saijo, Kenji Otsuka, Satoshi Sakaguchi, Yuko Toyoda, Hisatsugu Goto, Hiroshi Kawano, Masahiko Azuma, Fumitaka Ogushi, Yasuhiko Nishioka	20
14	SU6668, a multiple tyrosine kinase inhibitor, inhibits progression of human malignant pleural mesothelioma in an orthotopic model 2012 ·Respirology ·(unknown), Masaki Hanibuchi, Hisatsugu Goto, Takuya Kuramoto, (unknown), Soji Kakiuchi, Seidai Sato, Satoshi Sakaguchi, (unknown), Yasuhiko Nishioka, Shin‐ichi Akiyama, Saburo Sone	11
15	Laparoscopic liver resection for liver tumor using a microwave tissue coagulator 2011 ·Journal of Microwave Surgery ·(unknown), (unknown), Satoshi Sakaguchi, (unknown), (unknown), Koichiro Ishida, (unknown), Hiroyuki Tanishima, (unknown), Masamichi Kimura, (unknown), Tetsuya Horiuchi, Katsuyoshi Tabuse	1
16	Erlotinib prevents experimental metastases of human small cell lung cancer cells with no epidermal growth factor receptor expression 2011 ·Clinical & Experimental Metastasis ·(unknown), Hisatsugu Goto, Masaki Hanibuchi, Hirohisa Ogawa, Takuya Kuramoto, Minako Suzuki, Atsuro Saijo, Soji Kakiuchi, (unknown), Satoshi Sakaguchi, Yoichiro Moriya, Saburo Sone, Yasuhiko Nishioka	6
17	Gender difference in bone metastasis of human small cell lung cancer, SBC-5 cells in natural killer-cell depleted severe combined immunodeficient mice 2010 ·Clinical & Experimental Metastasis ·Satoshi Sakaguchi, Hisatsugu Goto, Masaki Hanibuchi, (unknown), Hirokazu Ogino, Soji Kakiuchi, Hisanori Uehara, Seiji Yano, Yasuhiko Nishioka, Saburo Sone	9
18	The role of PET scan for the detection of incidental gastrointestinal tract lesions in patients examined for lung cancer. 2010 ·Journal of Clinical Oncology ·Kazutoshi Isobe, Y. Hata, Satoshi Sakaguchi, Yujiro Takai, S. Sasamoto, (unknown), Kentaro Takagi, Shigenori Homma	0
19	[A case of pulmonary parenchymal endometriosis]. 2005 ·PubMed ·Hirohisa Ogawa, (unknown), Hiroyuki Doi, (unknown), Satoshi Sakaguchi	3
20	Catalytic Reductive Alkylation of Secondary Amine with Aldehyde and Silane by an Iridium Compound 2005 ·The Journal of Organic Chemistry ·(unknown), Satoshi Sakaguchi, Yasutaka Ishii	131

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact